491 related articles for article (PubMed ID: 27783266)
1. Bringing Curcumin to the Clinic in Cancer Prevention: a Review of Strategies to Enhance Bioavailability and Efficacy.
Mahran RI; Hagras MM; Sun D; Brenner DE
AAPS J; 2017 Jan; 19(1):54-81. PubMed ID: 27783266
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-cyclodextrin complexes enhanced the anti-cancer effects of curcumin.
Zhang L; Man S; Qiu H; Liu Z; Zhang M; Ma L; Gao W
Environ Toxicol Pharmacol; 2016 Dec; 48():31-38. PubMed ID: 27716533
[TBL] [Abstract][Full Text] [Related]
3. Curcumin: the story so far.
Sharma RA; Gescher AJ; Steward WP
Eur J Cancer; 2005 Sep; 41(13):1955-68. PubMed ID: 16081279
[TBL] [Abstract][Full Text] [Related]
4. Curcumin nanomedicine: a road to cancer therapeutics.
Yallapu MM; Jaggi M; Chauhan SC
Curr Pharm Des; 2013; 19(11):1994-2010. PubMed ID: 23116309
[TBL] [Abstract][Full Text] [Related]
5. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials.
Strimpakos AS; Sharma RA
Antioxid Redox Signal; 2008 Mar; 10(3):511-45. PubMed ID: 18370854
[TBL] [Abstract][Full Text] [Related]
6. Curcumin therapeutic promises and bioavailability in colorectal cancer.
Shehzad A; Khan S; Shehzad O; Lee YS
Drugs Today (Barc); 2010 Jul; 46(7):523-32. PubMed ID: 20683505
[TBL] [Abstract][Full Text] [Related]
7. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
Shehzad A; Wahid F; Lee YS
Arch Pharm (Weinheim); 2010 Sep; 343(9):489-99. PubMed ID: 20726007
[TBL] [Abstract][Full Text] [Related]
8. Chemopreventive efficacy of curcumin-loaded PLGA microparticles in a transgenic mouse model of HER-2-positive breast cancer.
Grill AE; Shahani K; Koniar B; Panyam J
Drug Deliv Transl Res; 2018 Apr; 8(2):329-341. PubMed ID: 28417445
[TBL] [Abstract][Full Text] [Related]
9. The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer.
Heger M; van Golen RF; Broekgaarden M; Michel MC
Pharmacol Rev; 2014; 66(1):222-307. PubMed ID: 24368738
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Applications of Curcumin Nanoformulations.
Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
[TBL] [Abstract][Full Text] [Related]
11. A short review on chemical properties, stability and nano-technological advances for curcumin delivery.
Slika L; Patra D
Expert Opin Drug Deliv; 2020 Jan; 17(1):61-75. PubMed ID: 31810374
[No Abstract] [Full Text] [Related]
12. Recent advances in curcumin nanoformulation for cancer therapy.
Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
[TBL] [Abstract][Full Text] [Related]
13. Oral bioavailability of curcumin: problems and advancements.
Liu W; Zhai Y; Heng X; Che FY; Chen W; Sun D; Zhai G
J Drug Target; 2016 Sep; 24(8):694-702. PubMed ID: 26942997
[TBL] [Abstract][Full Text] [Related]
14. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer.
Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
J Control Release; 2015 Jul; 209():110-9. PubMed ID: 25912409
[TBL] [Abstract][Full Text] [Related]
15. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro.
Li H; Zhang N; Hao Y; Wang Y; Jia S; Zhang H; Zhang Y; Zhang Z
Drug Deliv; 2014 Aug; 21(5):379-87. PubMed ID: 24160816
[TBL] [Abstract][Full Text] [Related]
16. Curcumin: a boon to colonic diseases.
Sareen R; Jain N; Pandit V
Curr Drug Targets; 2013 Sep; 14(10):1210-8. PubMed ID: 23768171
[TBL] [Abstract][Full Text] [Related]
17. Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management.
Moon DO
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474160
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of curcumin.
Sharma RA; Steward WP; Gescher AJ
Adv Exp Med Biol; 2007; 595():453-70. PubMed ID: 17569224
[TBL] [Abstract][Full Text] [Related]
19. In vitro cytotoxicity and cellular uptake of curcumin-loaded Pluronic/Polycaprolactone micelles in colorectal adenocarcinoma cells.
Raveendran R; Bhuvaneshwar G; Sharma CP
J Biomater Appl; 2013 Mar; 27(7):811-27. PubMed ID: 22274881
[TBL] [Abstract][Full Text] [Related]
20. Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art.
Ahmad MZ; Alkahtani SA; Akhter S; Ahmad FJ; Ahmad J; Akhtar MS; Mohsin N; Abdel-Wahab BA
J Drug Target; 2016; 24(4):273-93. PubMed ID: 26066739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]